157 related articles for article (PubMed ID: 12266199)
21. Effects of the triphasic oral contraceptive on lipid and lipoprotein metabolism.
Kirumbi LW; Maina FW; Sekadde Kigondu CB; Mati JK
J Obstet Gynaecol East Cent Africa; 1991; 9(1):23-9. PubMed ID: 12316812
[TBL] [Abstract][Full Text] [Related]
22. [The triphasic pill].
Belaisch J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
[TBL] [Abstract][Full Text] [Related]
23. [Disease and contraception. Recent aspects].
Rozenbaum H
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):431-6. PubMed ID: 12280211
[TBL] [Abstract][Full Text] [Related]
24. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives and plasma lipids.
Dhillon MK; Sarkar AK; Gupta AN; Devi PK
J Obstet Gynaecol India; 1972; 22(6):622-6. PubMed ID: 12332899
[TBL] [Abstract][Full Text] [Related]
26. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
[TBL] [Abstract][Full Text] [Related]
27. [Current issues in contraception].
Audebert AJ
Contracept Fertil Sex (Paris); 1985 Feb; 13(2):467-73. PubMed ID: 12339971
[TBL] [Abstract][Full Text] [Related]
28. [The effect of intrauterine contraceptive devices on the endometrium].
Sheppard BL; Bonnar J
Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
[TBL] [Abstract][Full Text] [Related]
29. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
[TBL] [Abstract][Full Text] [Related]
30. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
31. [Oral contraception: advantages of estrogen reduction].
Cohen J
Contracept Fertil Sex (Paris); 1993 Jun; 21(6):489-94. PubMed ID: 12318239
[TBL] [Abstract][Full Text] [Related]
32. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R
Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566
[TBL] [Abstract][Full Text] [Related]
33. [Sex steroids and vascular risk].
Rozenbaum H
Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
[TBL] [Abstract][Full Text] [Related]
34. What role do lipid levels play in managing OC patients?
Contracept Technol Update; 1987 Mar; 8(3):29-32. PubMed ID: 12341244
[TBL] [Abstract][Full Text] [Related]
35. [Post-coital contraception].
Serfaty D
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207
[TBL] [Abstract][Full Text] [Related]
36. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
37. Oestroprogestogen interference on some haematochemical parameters: glycaemia, lipid metabolism and hepatic functionality (author's transl).
Chieffi O; Brogioni M; Saltarelli O; Pecchioli S; Benardi M
Patol Clin Ostet Ginecol; 1981; 9(1):7-17. PubMed ID: 12278646
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
39. [Hyperlipidemia aggravated or induced by combined oral contraceptives: preliminary results of a decision-making scheme for the prevention of cardiovascular episodes].
Narboni G; Seklaoui T; Gillet JY; Colette C; Grandmottet P
J Med Besancon; 1978; 14(3-4):107-10. PubMed ID: 12338582
[TBL] [Abstract][Full Text] [Related]
40. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
Rozenbaum H
Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
